Background: Human serum adiponectin exists in 3 multimer forms: high molecular weight (HMW), middle molecular weight, and low molecular weight (LMW), with some of the latter bound to albumin (Alb)-LMW. Some studies have suggested that adiponectin crosses the blood-brain barrier and plays a central role in energy homeostasis. Methods: To determine cerebrospinal fluid (CSF) adiponectin at extremely low concentrations, we modified the protocol of the ELISA system used to assay serum adiponectin. The 3 multimers of adiponectin were measured separately by pretreating CSF with 2 proteases. We measured the CSF adiponectin concentrations in anonymous human samples (n ‫؍‬ 19). The molecular sizes of adiponectin in CSF pretreated with proteases or untreated were determined by use of native PAGE and immunoblotting. Results: The ELISA system measured adiponectin in the range of 1.0 -167 g/L. The between-assay imprecision estimates (CVs) were 6%-17% for the 3 forms. The mean total CSF adiponectin concentration (7.2 g/L) was ϳ1/ 1000 of the mean concentration in serum. Unlike serum adiponectin, the LMW and Alb-LMW forms predominated in all of the CSF samples. Immunoblotting analysis revealed that most LMW forms were bound to Alb, although the HMW form was detected in some samples. Conclusions: The modified ELISA system measures the 3 multimers separately and is sufficiently sensitive to measure adiponectin in CSF.
weight without substantial inhibition of food intake. Furthermore, intravenous adiponectin injection induced a Ͼ3-fold increase in cerebrospinal fluid (CSF) adiponectin concentration (4 ) . In contrast, a study of humans revealed that the adiponectin concentration in CSF made up only 0.1% of the serum adiponectin concentration, suggesting that adiponectin does not cross the blood-brain barrier (5 ) . Hence, controversy remains as to whether adiponectin can cross the blood-brain barrier under physiological conditions.
Adiponectin in human blood exists as 3 multimers with distinct molecular sizes: trimeric low molecular weight (LMW), hexameric middle molecular weight (MMW), and high molecular weight (HMW) forms (6 ) . Some of the LMW adiponectin exists as albumin (Alb)-bound forms (Alb-LMW) (7 ) . The molecular weights of adiponectin affect the strength of their metabolic actions. Several studies have suggested that HMW adiponectin and the ratio of HMW adiponectin to total adiponectin are more closely associated with insulin sensitivity and metabolic syndrome than is total adiponectin (8, 9 ) . ELISAs for measuring the 3 multimers separately (10 ) are available in Asia (Daiichi Pure Chemicals), the US, and the European Union (ALPCO Diagnostics).
We developed and tested a highly sensitive ELISA system for measuring CSF adiponectin and examined whether HMW adiponectin is detectable in human CSF. To measure extremely low concentrations of adiponectin in CSF, we modified the protocol of the ELISA used to measure serum adiponectin (10 ) . Human CSF was obtained from residual clinical samples that had normal cell counts and CSF concentrations of total protein, Alb, IgG, ␤ 2 -macroglobulin, glucose, lactate dehydrogenase, and chloride. We excluded samples in which erythrocyte contamination was detected by microscopic examination. After ensuring confidentiality of the identities of the sample donors, their CSF samples were labeled only with age and sex and were sent to our laboratory. To ensure that the samples were not contaminated with erythrocytes, we examined all of the CSF samples after low-speed centrifugation. Finally, we obtained 19 CSF samples [9 males and 10 females; mean (SD) age 51.6 (17.2) years] and stored them in a deep-freezer until use. Informed consent was obtained from all of the study participants, and the procedures were strictly in accordance with the statement of the Japanese Society of Laboratory Medicine on the use of residual clinical samples (11 ) .
This modified ELISA system enabled us to measure the 3 multimers separately by pretreating the samples with 2 proteases. A total of 150 L of CSF is required to measure the concentrations of total adiponectin and all 3 multimers. To determine total adiponectin, we mixed 50 L of CSF with 50 L of pretreatment buffer containing no protease [50 mmol/L Tris-HCl (pH 8.0)]. The mixture was added to 50 L of sample buffer [100 mmol/L sodium citrate (pH 3.0) containing 20 g/L sodium dodecyl sulfate
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Clinical Chemistry 53, No. 8, 2007 (SDS)]. For selective MMW ϩ HMW adiponectin determination, 50 L of CSF was incubated with the pretreatment buffer containing 1.0 g/L protease A Amano (Amano Enzyme) for 20 min at 37°C. The mixture was then added to 50 L of the sample buffer. For selective HMW adiponectin determination, we incubated 50 L of CSF with the pretreatment buffer containing 3.75 kU/L of proteinase K (Roche Diagnostics) for 20 min at 37°C. The mixture was then added to 50 L of the sample buffer.
These pretreated samples were further diluted 31-fold with PBS (15 mmol/L, pH 7.5) containing 10 g/L BSA and 0.5 g/L Tween 20 (BSA-PBST). Each well of the polystyrene microtiter plates (Nunc) was coated with 50 L of antihuman adiponectin monoclonal antibody (No. 64405; 5 mg/L in PBS) (10 ) and incubated overnight at 4°C. After PBST rinsing, the wells were blocked with 100 L of BSA-PBST at room temperature for 2 h. The calibrators (0 -1.8 g/L dimeric adiponectin from human serum) (10 ) or diluted samples (50 L each) were placed in the wells and incubated at room temperature for 2 h. After rinsing with PBST, 50 L of antihuman adiponectin biotinylated monoclonal antibody (No. 64404) (10 ) was added to each well, and the plate was incubated at room temperature for 1 h. After PBST rinsing, the biotinylated antibody was allowed to react with horseradish peroxidase-conjugated streptavidin (Pierce) at room temperature for 30 min. The trapped adiponectin-antibody complexes were then washed extensively and incubated with substrate solution (o-phenylenediamine in citrate buffer, pH 5.0, containing hydrogen peroxide) at room temperature for 20 min; the absorbance was measured at 492 nm. The concentrations of MMW and LMW (including Alb-LMW) adiponectin were obtained by subtracting the HMW concentration from the MMW ϩ HMW concentrations and the MMW ϩ HMW concentrations from the total adiponectin concentration, respectively. In the modified ELISA, the analytical limit of detection (12 ) was ϳ1.0 g/L, and the calibration curve was linear up to 167 g/L (y ϭ 1.10x ϩ 0.14, r ϭ 0.999). Decreasing the sample dilution and increasing the sample incubation and substrate reaction times rendered this modified system ϳ200 times more sensitive than the original system used to measure serum adiponectin. We confirmed that the curve of measured values of serially diluted CSF samples paralleled the calibration curve (Fig. 1A) . The intraassay CVs (n ϭ 8) were 7.3% and 2.7% at adiponectin concentrations of 7.1 and 17.8 g/L, respectively. The interassay CVs (n ϭ 4) were 6.3%, 17.2%, and 5.8% for the total adiponectin, MMW ϩ HMW, and HMW assays, respectively, at adiponectin concentrations of 19.0 g/L.
Despite the extremely low CSF-adiponectin concentrations, we measured adiponectin successfully in 19 clinical samples ( Table 1 ). The mean (SD) total CSF adiponectin concentration was 7.2 (7.2) g/L, which is ϳ1000 times lower than the serum adiponectin concentration. We also used electrophoresis to quantify the total adiponectin (A), linearity of the dilution curves of human CSF samples. After the 3 human CSF samples (Table 1 , sample nos. 1-3) were treated according to the sample pretreatment procedure outlined for the total adiponectin assay, the samples were further diluted serially with BSA-PBST. (B), typical Western blotting analysis of adiponectin multimers in human CSF. Human CSF (4 L; sample nos. 1-4) was separated using native PAGE and analyzed with Western blotting. (C), detection of the LMW form of adiponectin. Human CSF (10 L; sample nos. 1-4) was separated using nonheating SDS-PAGE and analyzed with Western blotting. (D), selectivity of protease digestion. After human CSF (sample no. 4) was treated with protease A Amano or proteinase K according to the sample pretreatment procedure (without sample buffer), 4 L each of the pretreated samples were separated using native PAGE and analyzed with Western blotting.
concentrations. The adiponectin multimers were converted into the dimer by heat denaturation and subjected to SDS-PAGE. The dimeric adiponectin bands were visualized by Western blotting with goat antiadiponectin antibody (R&D Systems) and quantified by densitometric intensity, which increased linearly from 1.0 to 25 g/L. We detected a strong positive correlation (n ϭ 19, r ϭ 0.940) between the total adiponectin values determined by the 2 methods.
In all 19 samples, the LMW adiponectin was the dominant form of the 3 multimers (Table 1 ). In 16 of the 19 samples, the MMW or HMW concentrations were below the detection limits. In 3 samples, all 3 adiponectin multimers were detected. For these 3 samples, the mean (SD) ratios of HMW, MMW, and LMW (including Alb-LMW) to total adiponectin were significantly different from the reported values for the serum samples (n ϭ 47): 0.18 (0.04) vs 0.39 (0.13), P Ͻ0.05; 0.15 (0.01) vs 0.27 (0.05), P Ͻ0.005; 0.69 (0.05) vs 0.34 (0.10), P Ͻ0.005, respectively, according to the Mann-Whitney U-test (10 ) .
To confirm these results, we separated the same CSF samples using 2%-15% native PAGE followed by Western blotting against adiponectin using goat antiadiponectin antibody (10 ) . The adiponectin multimers in the CSF samples were at the same positions as those of the serum adiponectin multimers (Fig. 1B) . As expected, the CSF samples showed considerably weaker MMW and HMW bands and clearer Alb-LMW (double-stained) bands than those observed in the serum control (7 ) . Such double staining might result from hydroxylation or glycosylation of the Alb-LMW form (13 ) . Because the LMW form cannot be detected clearly in native PAGE analysis, we used nonheating SDS-PAGE analysis to separate the LMW form from CSF (6 ) and thus confirmed the existence of the LMW form in human CSF (Fig. 1C) .
Finally, we examined whether protease A Amano and proteinase K selectively digest the CSF adiponectin multimers. We used native PAGE and Western blotting to analyze the digested products of CSF (10 ) . Consequently, we obtained HMW and MMW adiponectin after protease A Amano digestion and HMW adiponectin after proteinase K digestion (Fig. 1D) . As with serum samples, these selective digestions enabled us to measure the 3 multimers in CSF samples.
The predominance of the smaller molecular forms in human CSF is supported by a recent report (14 ) . In men, but not in women, the CSF adiponectin concentrations correlated positively with serum adiponectin and negatively with body mass index. Furthermore, adiponectin receptors were detected in the brain (4, 5 ) . These results suggest that the presence of CSF adiponectin did not result from contamination with peripheral blood during CSF sampling.
In conclusion, our modified ELISA system is sufficiently sensitive for measuring CSF adiponectin, and it can measure the 3 multimers. Although LMW (including Alb-LMW) adiponectin was found to be the dominant form in this set of human CSF samples, HMW and MMW adiponectin multimers were also detected in some samples. Additional studies are required to clarify how the adiponectin multimers are transported across the bloodbrain barrier and whether they play central roles in energy homeostasis. Our modified ELISA system will serve as a useful tool for future studies using CSF samples.
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Results:
The ability of most instruments to accurately genotype single-base changes by amplicon melting was limited by spatial temperature variation across the plate (SD of T m ‫؍‬ 0.020 to 0.264°C). Other variables such as data density, signal-to-noise ratio, and melting rate also affected heterozygote scanning. Conclusions: Different instruments vary widely in their ability to genotype homozygous variants and scan for heterozygotes by whole amplicon melting analysis. Instruments specifically designed for high-resolution melting, however, displayed the least variation, suggesting better genotyping accuracy and scanning sensitivity and specificity.
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Melting curve analysis has grown in sophistication from genotyping single-base variants with fluorescence resonance energy transfer probes (1 ) to inferring and differentiating sequence homologies through high-resolution amplicon melting with DNA binding dyes (2) (3) (4) . These advanced techniques are already being adapted to existing real-time PCR instruments. In our prior studies (5, 6 ), we evaluated the melting capabilities of 9 melting instruments found in our laboratory. These instruments varied in ability to detect homozygous mutants as well as to identify single-and double-heterozygous samples. The ability to differentiate complex melting species depends on the quality of the melting curve generated. Since our initial reports, 7 additional instruments have become available for genotyping and heterozygote scanning. Understanding the melting capabilities of these instruments should guide the appropriate use of different techniques.
As previously described (5, 6 ), a 110-bp fragment of the ␤-globin gene including the sickle cell anemia locus (HBB c. 20AϾT) was amplified by PCR in the presence of a DNA binding dye. A single patient sample of each genotype [wild-type, homozygous, and heterozygous HBB c. 20AϾT and double-heterozygote HBB c. (9CϾT; 20AϾT)] were amplified, pooled by genotype, and reallocated for instrument evaluation. Melting curves were obtained with the Applied Biosystems 7300, Corbett Life Science Rotor-Gene 6500HRM, Eppendorf Mastercycler® RealPlex4S, Idaho Technology LightScanner® (384 well), Roche LightCycler® 480 (96-and 384-well models), and Stratagene Mx3005p. Melting curves were obtained at 0.1°C/s if possible. For instruments able to perform only step monitoring, the melting cycle was monitored at 10 acquisitions/°C with a 10-s hold. A single 96/384-well plate or 72-sample rotor containing homogenous wildtype amplicon and LCGreen® Plus (Idaho Technology) were used to determine temperature homogeneity [expressed as the melting temperature (T m ) SD], melting curve superimposability (expressed as the temperatureshifted T m SD), signal-to-noise ratio, data density, and, for the heat block instruments, dynamic thermal profiles. Because of spectral incompatibilities with LCGreen Plus, SYBR Green I (Invitrogen) was used with the Stratagene's Mx3005p.
Heterozygote scanning was also evaluated by melting each of the 4 genotypes in triplicate. For heat block instruments, the amplicons were placed in identical positions randomly dispersed across the plate, with an equal volume of water filling the intervening spaces. The resulting melting curves were temperature-shifted for resolving single-and double-heterozygous samples.
The normalized melting curves are shown in Fig. 1A . The apparent temperature variation within a genotype was highly dependent on the instrument used. After temperature shifting, the T m variation within a genotype was usually decreased (Fig. 1B) , particularly in the case of the 7300 and LC480 instruments, for which temperature shifting enabled heterozygote differentiation. The displacement of the double heterozygote was so great that it was distinguishable in all cases, but accurate detection of the single heterozygote was not achieved with all instruments. Table 1 shows instrument variables and measured T m SDs compiled from this and prior studies (5, 6 ) . The T m SDs directly affect the ability to separate different homozygous melting curves. The main contributing variable appears to be temperature homogeneity. As seen previously, air-based instruments and instruments with individual sample temperature control have lower T m SDs (0.018 -0.065) than their heat-block counterparts (0.092-0.274). Block systems with thermal electric heaters had lower T m SDs (0.092-0.102) then Peltier-based systems (0.117-0.274). The dynamic melting profile for the 96-well and 384-well heat blocks are shown in Fig. 1C . Thermal edge effects and the Peltier configuration can be inferred from the thermal maps of the heat block instruments.
Genotyping single-base variants with fluorescent probes usually results in T m differences for the matched and mismatched species of 4 -10°C. All the instruments studied are capable of genotyping at this level of resolution. When genotyping is performed by amplicon melting, however, T m differences are much smaller. The mean T m difference of homozygotes of class 1 and class 2 single-nucleotide polymorphisms (SNPs) was 1°C, and almost all have a T m difference Ͼ0.5°C (7 ) . In 8 of the instruments, estimated error rates were Ͻ1% at this degree of resolution (SD Ͻ0.109) (5 ) . When the melting difference was decreased to Ͼ0.25°C, as in typical class 3 and class 4 SNPs, only 5 of the instruments evaluated had an estimated error rate of Ͻ1% (SD Ͼ0.054).
Different homozygotes each produce only a single homoduplex species. Therefore, genotyping by T m (determined as the temperature at 50% of the normalized fluorescence) is straightforward and has an accuracy directly correlated to temperature homogeneity. The T m variation of block-based systems is greater than that for air-based or individual sample systems. This variation is attributable to difficulties in uniformly heating large metal blocks and assigning a single temperature to represent the entire block. The thermal control of multiple samples is improved with air-based systems, for which rapid mixing forces temperature homogeneity. Alternatively, single-sample systems also fared well, because spatial temperature homogeneity is not a concern, allowing better temperature control and measurement.
Detection of heterozygous samples by amplicon melting is more complex than homozygote differentiation. Heterozygotes differ primarily in melting curve shape rather than absolute T m . These differences are often visualized after temperature shifting to superimpose the curves, allowing easy visualization and grouping by melting curve shape. For any heterozygous sample, the resulting melting curve is a combination of 2 homoduplexes and 2 heteroduplexes that form as the samples are cooled. Mismatched duplexes melt at lower temperatures than homoduplexes. About half of the instruments surveyed performed heterozygote scanning well. Multiple variables affect the quality of DNA melting curves, including data density, signal-to-noise ratio, and melting rate. For example, increasing the data density beyond 10 points/°C allows for more melting information to be displayed and potentially the resolution of more duplex species. In addition, the 3 melting domains of the double heterozygotes were easier to resolve in melting curves with higher signal-to-noise ratios and good superimposability (low temperatureshifted T m SD). Improved resolution also becomes important in recognizing unknown variants that occur within the amplicon studied (8 ) . Prior reports suggest that better heteroduplex detection is obtained at faster melting rates and higher signal-to-noise ratios (9 ) . Although a general correlation with these factors was observed, the significance of each factor and their interactions will require further study.
Limitations of the current study include the assumption that each instrument and its performance are typical. not shown). Another concern is that the number of samples studied was influenced by the sample capacity of each instrument (96 or 384 for plates and 72 or 32 for rotors). These within-run variations were compared to 32 interrun variances on single sample instruments. Melting curve analysis with saturating DNA dyes is a simple method for genotyping and scanning (7 ) . Homozygous samples can often be genotyped by an absolute change in T m (10 ) , while heterozygous samples can be identified through changes in the shape of the melting curve (11, 12 ) . Recently, internal temperature controls have been used to correct for T m variation seen in lowresolution instruments (13) (14) (15) . These controls provide a reference to correctly genotype homozygous alleles regardless of the temperature homogeneity of the system. The detection of subtle sequence changes for variant scanning will continue to rely on the resolution of melting instruments.
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